menu search

CymaBay Announces Closing of Upsized $258.7 Million Public Offering of Common Stock and Pre-Funded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

CymaBay Announces Closing of Upsized $258.7 Million Public Offering of Common Stock and Pre-Funded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
NEWARK, Calif., Sept. 14, 2023 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (Nasdaq: CBAY), a clinical-stage biopharmaceutical company focused on developing innovative therapies for liver and other chronic diseases with high unmet medical need, today announced the closing of its previously announced underwritten public offering of common stock and pre-funded warrants. CymaBay sold 14,521,307 shares of […] The post CymaBay Announces Closing of Upsized $258.7 Million Public Offering of Common Sto... Read More
Posted: Sep 14 2023, 20:57
Author Name: forextv
Views: 112556

Search within

Pages Search Results: